Yangguang Nuohe: Intends to purchase 100% equity of Langyan Life. There have been no abnormal fluctuations in the stock trading.

Sunshine Nuohe Announcement: Beijing Sunshine Nuohe Pharmaceutical Research Co., Ltd. intends to purchase 100% equity of Jiangsu Langyan Life Science Technology Holding Co., Ltd. through the issuance of shares and convertible corporate bonds, and to issue shares to raise matching funds from no more than 35 specific investors. In the 20 trading days before the first announcement of this transaction, the cumulative increase in the company's stock price was 9.82%. Excluding the impact of market factors and peer sector factors, the cumulative increase or decrease in the company's stock price in the 20 trading days before the announcement of this transaction did not exceed 20%, and did not meet the cumulative increase or decrease standards specified in the "Shanghai Stock Exchange Listed Company Self-Regulation 1 Regulatory Guidelines No. 6 - Major Asset Restructuring". The company's stock trading did not experience abnormal fluctuations.